TV4 morning show: Report: New Drugs Are Not Reaching All Breast Cancer Patients
15 October 2024
Advances in breast cancer research are providing entirely new opportunities
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Advances in breast cancer research are providing entirely new opportunities
Johan Hartman is a guest at the Johnson & Johnson
Stratipath is thrilled to announce a collaboration with Roche, the
In collaboration with iBreastBook, Johan Hartman, co-founder of Stratipath, participated
Stratipath is thrilled to announce our active role in advancing
Stratipath is excited to announce the publication of a new
Stratipath Breast, is now officially registered with the Medicines and
Stratipath is proud to be a part of Proscia’s new
Johan Hartman is a guest at the Johnson & Johnson
Advances in breast cancer research are providing entirely new opportunities
Johan Hartman is a guest at the Johnson & Johnson